Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 109, doi. 10.1038/cgt.2012.92
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2013 AND VI 20 AND IP 2
Results: 11
1
2
Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 94, doi. 10.1038/cgt.2012.90
- By:
- Publication type:
- Article
3
Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 70, doi. 10.1038/cgt.2012.95
- By:
- Publication type:
- Article
4
Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 77, doi. 10.1038/cgt.2012.86
- By:
- Publication type:
- Article
5
RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 101, doi. 10.1038/cgt.2012.91
- By:
- Publication type:
- Article
6
The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 88, doi. 10.1038/cgt.2012.89
- By:
- Publication type:
- Article
7
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 65, doi. 10.1038/cgt.2012.87
- By:
- Publication type:
- Article
8
Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 117, doi. 10.1038/cgt.2012.94
- By:
- Publication type:
- Article
9
c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 82, doi. 10.1038/cgt.2012.88
- By:
- Publication type:
- Article
10
Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 133, doi. 10.1038/cgt.2012.97
- By:
- Publication type:
- Article
11
Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 2, p. 125, doi. 10.1038/cgt.2012.96
- By:
- Publication type:
- Article